Cita APA

Aichholzer, F., Klafki, H., Ogorek, I., Vogelgsang, J., Wiltfang, J., Scherbaum, N., . . . Wirths, O. (2021). Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease. Alzheimers Res Ther.

Citación estilo Chicago

Aichholzer, Freyja, Hans-Wolfgang Klafki, Isabella Ogorek, Jonathan Vogelgsang, Jens Wiltfang, Norbert Scherbaum, Sascha Weggen, and Oliver Wirths. "Evaluation of Cerebrospinal Fluid Glycoprotein NMB (GPNMB) As a Potential Biomarker for Alzheimer’s Disease." Alzheimers Res Ther 2021.

Cita MLA

Aichholzer, Freyja, et al. "Evaluation of Cerebrospinal Fluid Glycoprotein NMB (GPNMB) As a Potential Biomarker for Alzheimer’s Disease." Alzheimers Res Ther 2021.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.